CogstateCOGZF 90 Gross Margin % is 50.71% as of Dec. 2025, which is 9% below its 10-year median of 55.52. GuruFocus rates COGZF with a GF Score™ of 90/100 and a GF Value™ of $1.58 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Cogstate ranks better than 66.09% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Cogstate's Gross Profit for the
six
months ended in Dec. 2025 was $13.07 Mil. Cogstate's Revenue for the
six
months ended in Dec. 2025 was $25.78 Mil. Therefore, Cogstate's Gross Margin % for the quarter that ended in Dec. 2025 was 50.71%.
The historical rank and industry rank for Cogstate's Gross Margin % or its related term are showing as below:
COGZF'
s Gross Margin % Range Over the Past 10 Years
Min: 43.9 Med: 55.52 Max: 60.4
Current: 55.74
During the past 13 years, the highestGross Margin % of Cogstate was 60.40%. The lowest was 43.90%. And the median was 55.52%.
COGZF's Gross Margin % is ranked better than 66.09% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs COGZF: 55.74
Cogstate had a gross margin of 50.71% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Cogstate was 4.70% per year.
Cogstate (OTCPK:COGZF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Cogstate had a gross margin of 50.71% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Cogstate Gross Margin % Related Terms
Cogstate Gross Margin % Historical Data
* Premium members only.
The historical data trend for Cogstate's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COGZF vs VEEV, BTSG, TEM: Gross Margin % Comparison
For the Health Information Services subindustry, Cogstate's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cogstate Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Cogstate's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Cogstate (COGZF) has a Gross Margin % of 50.71% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Cogstate and its competitors. This is near median its historical median of 55.52. Over the past decade, Cogstate's Gross Margin % has ranged from 43.90 to 60.40. According to the industry distribution chart, Cogstate ranks #214 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 33.9%.
Is Cogstate's Gross Margin % too high?
Cogstate's current Gross Margin % of 50.71% is near median its 10-year median of 55.52. Over the past 10 years, this metric has ranged from a low of 43.90 to a high of 60.40. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Cogstate's value of 50.71% is 26.5% above this industry median. Based on the distribution chart, Cogstate ranks #214 out of 631 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cogstate has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cogstate ranks #214 out of 631 companies for Gross Margin %. This puts Cogstate in the upper half of its industry. The industry median Gross Margin % is 40.09. Cogstate's value of 50.71% is 26.5% above this benchmark. Historically, Cogstate's own Gross Margin % has ranged from 43.90 to 60.40 over the past decade. While the company's 10-year median is 55.52 vs. the industry median of 40.09, Cogstate has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cogstate's current Gross Margin % of 50.71% is 26.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Cogstate and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cogstate's current Gross Margin % is 50.71%, which is near median its own 10-year median of 55.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (COGZF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.58, compared to a current price of $1.89 — trading 19.6% above its estimated fair value. The current Gross Margin % is 50.71%, which is near median its 10-year median of 55.52 and 26.5% above the Healthcare Providers & Services industry median of 40.09. Cogstate's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Cogstate (COGZF), the current Gross Margin % is 50.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cogstate (COGZF) Overvalued in 2026?
Based on GuruFocus' analysis, Cogstate stock appears to be overvalued.
The current stock price of $1.89 is trading 19.6% above its estimated GF Value™ of $1.58.
GuruFocus considers Cogstate to be Modestly Overvalued.
Key valuation signals for COGZF:
Gross Margin %: 50.71% (near median its 10-year median of 55.52)
GF Value™: $1.58 vs. price of $1.89 (19.6% above fair value)
Industry Position: 26.5% above the Healthcare Providers & Services median (#214 of 631)
No single metric tells the full story. See the COGZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
90GF Score
Get the complete analysis for COGZF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COGZF has been successfully added to your 
